Atlas Trials

The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

Clinical trial NCT04600219 · UNKNOWN

Trial details

NCT number
NCT04600219
Sponsor
Ai Peng
Status
UNKNOWN
Study type
OBSERVATIONAL
Hemodialysis Complication
Start date
2018-01-01
Primary completion
2021-12-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.